Singh tells Conservatives to back off as House prepares for first pharmacare voteThe legislation is a central condition of the NDP’s political pact with the governing Liberals, and includes a program to cover select contraceptive and diabetes medications and supplies. ASA should not be recommended as an adjuvant treatment for breast cancerA U.S. and Canada study shows that ASA 300 mg daily does not improve risk of breast cancer recurrence or survival in individuals with high-risk nonmetastatic breast cancer. New Product: Bio-K+ Extra Stress Support with Sensoril Sensoril reduces cortisol levels, a stress marker, and helps with occasional sleep issues. NEW PRODUCT: Evolve eyedrops Evolve eyedrops are new lubricating eye drops for dry eyes. Immunocompromised patients shouldn’t take Miracle Reds powder, Health Canada says MacroLife Naturals markets Miracle Reds as a source of 19 fruits and berries containing probiotics, antioxidants and enzymes. NEW PRODUCT: hello unicorn deodorant Hello has launched its unicorn deodorant, an aluminum-free product made without baking soda, dyes or parabens. ‘Expensive, ineffective, and possibly harmful’: CBD is no panacea for pain according to new review A new article in the Journal of Pain looked at the results of 16 randomized, double-blind trials published on CBD and pain since 2019. What does science say about the ingredients in ‘functional’ beverages? Drinks promoted as offering mental or physical benefits beyond hydration are growing in popularity. Rimegepant (Nurtec ODT) now available for acute treatment of migraine Rimegepant is the second oral “gepant” for acute migraine to be marketed in Canada following ubrogepant (Ubrelvy). A natural deception: 3 marketing myths the supplement industry wants you to swallow These three major assumptions appear over and over in supplement marketing. First Previous 8 9 10 11 12 Next Last
